Quince Therapeutics
Quince Therapeutics (fka Cortexyme) is a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases.
Milestones
- Founded 2012
- Partnered 2018
- IPO 2019
Quince Therapeutics (fka Cortexyme) is a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases.